Item request has been placed!
×
Item request cannot be made.
×
Processing Request
miR-144 attenuates the host response to influenza virus by targeting the TRAF6-IRF7 signaling axis.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
- Publication Information:
Original Publication: San Francisco, CA : Public Library of Science, c2005-
- Subject Terms:
- Abstract:
Antiviral responses must rapidly defend against infection while minimizing inflammatory damage, but the mechanisms that regulate the magnitude of response within an infected cell are not well understood. miRNAs are small non-coding RNAs that suppress protein levels by binding target sequences on their cognate mRNA. Here, we identify miR-144 as a negative regulator of the host antiviral response. Ectopic expression of miR-144 resulted in increased replication of three RNA viruses in primary mouse lung epithelial cells: influenza virus, EMCV, and VSV. We identified the transcriptional network regulated by miR-144 and demonstrate that miR-144 post-transcriptionally suppresses TRAF6 levels. In vivo ablation of miR-144 reduced influenza virus replication in the lung and disease severity. These data suggest that miR-144 reduces the antiviral response by attenuating the TRAF6-IRF7 pathway to alter the cellular antiviral transcriptional landscape.
- References:
Cell Tissue Res. 2011 Jan;343(1):13-21. (PMID: 20848130)
Stem Cells. 2010 Feb;28(2):287-96. (PMID: 19911427)
J Innate Immun. 2017;9(2):145-161. (PMID: 27811478)
PLoS One. 2013 Sep 20;8(9):e74863. (PMID: 24073225)
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6. (PMID: 16885212)
PLoS One. 2013 Sep 26;8(9):e76560. (PMID: 24086750)
Annu Rev Microbiol. 2010;64:123-41. (PMID: 20477536)
Sci Signal. 2015 Dec 08;8(406):ra126. (PMID: 26645583)
Mol Cell Biol. 2008 Oct;28(20):6536-46. (PMID: 18710948)
Mol Syst Biol. 2008;4:218. (PMID: 18766178)
Sci Rep. 2015 Oct 09;5:14991. (PMID: 26450567)
Nat Rev Immunol. 2016 Apr 28;16(5):279-94. (PMID: 27121651)
Am J Pathol. 2010 Apr;176(4):1828-40. (PMID: 20110407)
J Immunol. 2009 Dec 15;183(12):7975-83. (PMID: 19923465)
J Immunol. 2009 Aug 1;183(3):2150-8. (PMID: 19596990)
PLoS Pathog. 2013;9(11):e1003773. (PMID: 24278020)
Cell. 2009 Jan 9;136(1):26-36. (PMID: 19135886)
Cell Host Microbe. 2013 Oct 16;14(4):435-45. (PMID: 24075860)
EMBO J. 1998 Nov 16;17(22):6660-9. (PMID: 9822609)
J Immunol. 2012 Dec 15;189(12):5965-75. (PMID: 23169590)
Nat Immunol. 2008 Apr;9(4):369-77. (PMID: 18345001)
PLoS One. 2009 May 25;4(5):e5674. (PMID: 19479062)
J Immunol. 2006 Aug 1;177(3):1817-24. (PMID: 16849492)
BMC Microbiol. 2013 May 10;13:104. (PMID: 23663545)
Immunity. 2000 Oct;13(4):539-48. (PMID: 11070172)
Cell Host Microbe. 2010 Oct 21;8(4):358-68. (PMID: 20951969)
Blood. 2009 Jan 29;113(5):1045-52. (PMID: 18971424)
PLoS Pathog. 2012 Jan;8(1):e1002484. (PMID: 22291592)
Eur J Immunol. 2009 Apr;39(4):1007-18. (PMID: 19283778)
Expert Rev Clin Immunol. 2014 Jul;10(7):963-71. (PMID: 24784476)
Immunity. 2015 Jun 16;42(6):1021-32. (PMID: 26084022)
Nat Immunol. 2004 Oct;5(10):1061-8. (PMID: 15361868)
BMC Genomics. 2013;14 Suppl 5:S17. (PMID: 24552551)
Cell. 2000 Dec 22;103(7):1071-83. (PMID: 11163183)
Am J Pathol. 2010 Jul;177(1):166-75. (PMID: 20508031)
Int Rev Immunol. 2009;28(3-4):139-54. (PMID: 19811319)
Blood. 2013 Feb 7;121(6):1016-27. (PMID: 23212522)
PLoS One. 2016 May 11;11(5):e0155104. (PMID: 27166678)
J Biol Chem. 2008 Dec 26;283(52):36211-20. (PMID: 18984593)
J Exp Med. 2010 Jul 5;207(7):1351-8. (PMID: 20513743)
EMBO J. 2008 Dec 17;27(24):3300-10. (PMID: 19020517)
Mol Cell Biol. 2012 Sep;32(17):3438-51. (PMID: 22733995)
Science. 2005 Sep 2;309(5740):1577-81. (PMID: 16141076)
J Immunol. 2010 Dec 15;185(12 ):7699-705. (PMID: 21048113)
Cell Host Microbe. 2015 Dec 9;18(6):714-22. (PMID: 26651947)
J Virol. 2014 Jul;88(14):8065-76. (PMID: 24807715)
Nature. 2005 Apr 7;434(7034):772-7. (PMID: 15800576)
J Gen Virol. 2014 Feb;95(Pt 2):350-62. (PMID: 24243730)
Nat Rev Immunol. 2008 Jul;8(7):559-68. (PMID: 18575461)
Cell. 2009 Jan 23;136(2):215-33. (PMID: 19167326)
Microbes Infect. 2010 Jan;12 (1):81-7. (PMID: 19782761)
J Exp Med. 2011 Jun 6;208(6):1189-201. (PMID: 21555486)
Genes Dev. 2010 Aug 1;24(15):1620-33. (PMID: 20679398)
Am J Pathol. 2007 Oct;171(4):1215-23. (PMID: 17717141)
Science. 2015 Apr 24;348(6233):448-53. (PMID: 25814066)
J Exp Med. 2010 Sep 27;207(10):2053-63. (PMID: 20837696)
Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15416-21. (PMID: 15492225)
- Grant Information:
R01 AI025032 United States AI NIAID NIH HHS; R01 AI032972 United States AI NIAID NIH HHS; R01 DK092318 United States DK NIDDK NIH HHS; U19 AI100627 United States AI NIAID NIH HHS
- Accession Number:
0 (MIRN144 microRNA, mouse)
0 (MicroRNAs)
0 (RNA, Messenger)
0 (TNF Receptor-Associated Factor 6)
0 (Traf7 protein, mouse)
0 (Tumor Necrosis Factor Receptor-Associated Peptides and Proteins)
- Publication Date:
Date Created: 20170406 Date Completed: 20170428 Latest Revision: 20230802
- Publication Date:
20230802
- Accession Number:
PMC5393898
- Accession Number:
10.1371/journal.ppat.1006305
- Accession Number:
28380049
No Comments.